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Introduction 
Intermittent parathyroid hormone 1-34 (teriparatide) is the N-fragment terminal of the 
intact hormone, currently in clinical use to treat osteoporosis. Unlike anti-catabolic agents 
such as bisphosphonates, PTH 1-34 not only affects the osteoclast, but also up regulates 
bone formation via both modelling and remodelling mechanisms. The actions of iPTH on 
mesenchymal stem cell differentiation (MSCs) may underpin a further method in the 
treatment of osteoporosis specifically, and for fracture healing in general. Stem cells from 
older female osteoporotic animals have reduced activity and poorer osteogenic potential; 
additionally, their migration to and retention at sites of increased bone turnover are 
reduced in comparison to cells from younger animals.  
The aim of this study was to isolate bone marrow derived MSCs from both young Wild Type 
(WT) and ovarectomized senile (OVX) rats, then to investigate and compare the effect of 
pulsatile and continuous PTH administration on migration to SDF-1, proliferation and 
osteogenic differentiation.   
 
Methods 
MSCs were harvested from the femora of 6-9week Wistar rats, and from 10-13month 
ovarectomized rats with established osteopenia. Cells were cultured with 25, 50 and 
100nmMol of PTH 1-34 added to osteogenic media either continuously or in a pulsatile 
fashion for 6 hours in every 72hour cycle. ALP and Alizarin Red were used to assess the 
optimal concentration of PTH for osteogenic differentiation. Subsequently, proliferation was 
assessed with Alamar Blue and cells were seeded in a Boyden chamber to quantify the 
migration to SDF-1.As the data was parametric  a student t-test was used to analyse results, 
and a p value < 0.05 was considered significant. 
 
Results 
ALP and Alizarin Red parameters were significantly increased for both WT and OVX groups 
at 50nmMol of pulsatile PTH in comparison to groups cultured in 25 or 100nmMol. 
Continuous administration at all concentrations led to reduced calcium phosphate 
deposition by day 21 in all groups. Interestingly, in comparison to cells cultured in 
osteogenic media, 50nmMol of pulsatile PTH lead to statistically significant higher ALP and 
Alizarin Red measurements up to day 10 and 14 respectively in WT cells, and days 10 and 21 
in OVX cells (figure 1). 
The proliferation rate normalised against DNA was similar for both OVX and WT rats at all-
time points. PTH administration did not effect cell proliferation in any group (figure 2.) 
WT MSCs not only had improved osteogenic differentiation, but also showed increased 
migration to SDF-1 in comparison to OVX groups. Pulsatile PTH led to further increases in 
migration of both OVX and WT cells. 
Conclusion 
Intermittent PTH increases the osteogenic diffrentiation and migration of MSCs from both 
young and ovarectomised rats, though importantly this effect is not dose dependent. 
Ultimately, the role of PTH 1-34 on MSCs may lead to improved bone formation and cell 
homing capacity-particularly in the context of osteoporosis. 
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Figure 1.Alizarin Red production of young and ovarectomised cells in osteogenic media and at 50nmMol of PTH 
1-34. *p=<0.001, **p=<0.05 
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Figure 2. Alamar Blue normalised against cell DNA, showed no significant difference between WT and OVX 
cells, or by the addition of PTH 
